Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ASP Isotopes (ASPI) Research & Development (2022 - 2025)

ASP Isotopes has reported Research & Development over the past 4 years, most recently at $6.8 million for Q4 2025.

  • For Q4 2025, Research & Development rose 383.7% year-over-year to $6.8 million; the TTM value through Dec 2025 reached $12.4 million, up 293.69%, while the annual FY2025 figure was $12.4 million, 293.69% up from the prior year.
  • Research & Development for Q4 2025 was $6.8 million at ASP Isotopes, up from $3.1 million in the prior quarter.
  • Over five years, Research & Development peaked at $6.8 million in Q4 2025 and troughed at $65168.0 in Q4 2023.
  • A 4-year average of $1.1 million and a median of $383176.5 in 2022 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: tumbled 67.91% in 2023 and later soared 2073.03% in 2024.
  • Year by year, Research & Development stood at $81635.0 in 2022, then dropped by 20.17% to $65168.0 in 2023, then soared by 2073.03% to $1.4 million in 2024, then skyrocketed by 383.7% to $6.8 million in 2025.
  • Business Quant data shows Research & Development for ASPI at $6.8 million in Q4 2025, $3.1 million in Q3 2025, and $879925.0 in Q2 2025.